Biological and therapeutic applications of small RNAs

Kun Cheng; Ram I. Mahato

doi:10.1007/s11095-011-0609-0

Biological and therapeutic applications of small RNAs

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2961-2965
Number of pages	5
Journal	Pharmaceutical Research
Volume	28
Issue number	12
DOIs	https://doi.org/10.1007/s11095-011-0609-0
State	Published - Dec 2011
Externally published	Yes

ASJC Scopus subject areas

Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Organic Chemistry
Pharmacology (medical)

Access to Document

10.1007/s11095-011-0609-0

Cite this

@article{f543df71ae9044e99e9390185ebef8b4,

title = "Biological and therapeutic applications of small RNAs",

author = "Kun Cheng and Mahato, {Ram I.}",

note = "Funding Information: Professor of Pharmaceutical Sciences at the University of Missouri-Kansas City (UMKC). Dr. Cheng received his B.S. (1996) and M.S. (1999) in Phar- maceutical Sciences from China Pharmaceutical University. He also received another M.S. (2001) in Pharmacy from the National University of Singapore. He worked at the Brightfuture Pharmaceutical Company in HongKong prior to joining the University of Tennessee Health Science Center in 2002, where he received his Ph.D. (2007) in Pharmaceutical Sciences. Dr. Cheng{\textquoteright}s current research focuses on the development of novel drug delivery systems for small-molecule and macromolecular drugs; identification of tumor-specific artificial ligands for targeted drug delivery and tumor imaging; development of peptide modified prodrugs for chemotherapy; and therapeutic applications of siRNAs for the treatment of breast cancer, prostate cancer, and liver diseases. Much of the effort from Dr. Cheng{\textquoteright}s laboratory has dealt with the exploration of macromolecular therapeutics which have poor stability and inefficient cellular uptake. His research has been supported by the Department of Defense (DoD) and the National Institute of Health (NIH). Dr. Cheng received a Concept Award from the DoD Breast Cancer Research Program in 2008. Dr. Cheng is actively involved in various extramural professional activities. He edited a theme issue entitled “siRNA Delivery” for the journal Molecular Pharmaceutics in 2009. He currently serves on the editorial boards of ISRN Pharmaceutics and the International Journal of Pharmaceutical Engineering (IJPHE). Dr. Cheng has also been actively involved in the American Association of Pharmaceutical Scientists (AAPS) UMKC Student Chapter and the Pharmaceutical Sciences Graduate Student Association (PSGSA), serving as the faculty advisor. Dr. Cheng is the recipient of the 2011 AAPS New Investigator Grant Award in Pharmaceutics and Pharmaceutical Technology.",

year = "2011",

month = dec,

doi = "10.1007/s11095-011-0609-0",

language = "English (US)",

volume = "28",

pages = "2961--2965",

journal = "Pharmaceutical Research",

issn = "0724-8741",

publisher = "Springer New York",

number = "12",

}

TY - JOUR

T1 - Biological and therapeutic applications of small RNAs

AU - Cheng, Kun

AU - Mahato, Ram I.

N1 - Funding Information: Professor of Pharmaceutical Sciences at the University of Missouri-Kansas City (UMKC). Dr. Cheng received his B.S. (1996) and M.S. (1999) in Phar- maceutical Sciences from China Pharmaceutical University. He also received another M.S. (2001) in Pharmacy from the National University of Singapore. He worked at the Brightfuture Pharmaceutical Company in HongKong prior to joining the University of Tennessee Health Science Center in 2002, where he received his Ph.D. (2007) in Pharmaceutical Sciences. Dr. Cheng’s current research focuses on the development of novel drug delivery systems for small-molecule and macromolecular drugs; identification of tumor-specific artificial ligands for targeted drug delivery and tumor imaging; development of peptide modified prodrugs for chemotherapy; and therapeutic applications of siRNAs for the treatment of breast cancer, prostate cancer, and liver diseases. Much of the effort from Dr. Cheng’s laboratory has dealt with the exploration of macromolecular therapeutics which have poor stability and inefficient cellular uptake. His research has been supported by the Department of Defense (DoD) and the National Institute of Health (NIH). Dr. Cheng received a Concept Award from the DoD Breast Cancer Research Program in 2008. Dr. Cheng is actively involved in various extramural professional activities. He edited a theme issue entitled “siRNA Delivery” for the journal Molecular Pharmaceutics in 2009. He currently serves on the editorial boards of ISRN Pharmaceutics and the International Journal of Pharmaceutical Engineering (IJPHE). Dr. Cheng has also been actively involved in the American Association of Pharmaceutical Scientists (AAPS) UMKC Student Chapter and the Pharmaceutical Sciences Graduate Student Association (PSGSA), serving as the faculty advisor. Dr. Cheng is the recipient of the 2011 AAPS New Investigator Grant Award in Pharmaceutics and Pharmaceutical Technology.

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=83555166072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83555166072&partnerID=8YFLogxK

U2 - 10.1007/s11095-011-0609-0

DO - 10.1007/s11095-011-0609-0

M3 - Editorial

C2 - 22042644

AN - SCOPUS:83555166072

SN - 0724-8741

VL - 28

SP - 2961

EP - 2965

JO - Pharmaceutical Research

JF - Pharmaceutical Research

IS - 12

ER -

Biological and therapeutic applications of small RNAs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this